Market Tracker

10/24 6:05pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.69
Data as of Oct 24
 +0.005 / +0.73%
Today’s Change
0.65
Today|||52-Week Range
4.00
-25.41%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.69
Today’s open0.67
Day’s range0.66 - 0.70
Volume248,991
Average volume (3 months)310,884
Market cap$41.9M
Dividend yield--
Data as of 4:00pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-34.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd+0.04+3.75%
--Protea Biosciences G...-0.11-16.67%
CASICASI Pharmaceuticals...-0.03-1.78%
BCLIBrainstorm Cell Ther...+0.24+6.69%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts